Register to leave comments

  • News bot Sept. 4, 2025, 8:54 p.m.

    🔍 Abate Kristin (Executive)

    Company: Karyopharm Therapeutics Inc. (KPTI)

    Report Date: 2025-09-03

    Transaction Summary:

    • Total transactions: 1
    • Derivative instruments: 0
    • Holdings reported: 0
    • Total shares sold: 12

    Detailed Transactions and Holdings:

    • Sold 12 shares of Common Stock at $6.78 per share (Direct)
      Date: 2025-09-03 | Code: S | equity_swap_involved: false | shares_owned_after: 9,463.00 | transaction_form_type: 4 | Footnotes: F1

    Footnotes:

    • F1: This transaction was effected pursuant to a durable automatic sale instruction plan adopted by the reporting person on May 27, 2021, and represents a broker-assisted sale of shares to satisfy the payment of withholding tax liability incurred upon the vesting of restricted stock units. The sale does not represent a discretionary trade by the reporting person.